Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma oleh Ilaria Saltarella, Alexander Link, Aurelia Lamanuzzi, Christian Reichen, Joanna Robinson, Concetta Altamura, Assunta Melaccio, Antonio Giovanni Solimando, Roberto Ria, Maria Addolorata Mariggiò, Angelo Vacca, Maria Antonia Frassanito, Jean-François Desaphy